Table 2 Urinary symptoms and uroflowmetry results in 50 women affected by idiopathic OAB and sexual dysfunction before and 12- weeks after treatment with oral Mirabegron, 50 mg/day
From: The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
Urinary symptoms and uroflowmetry results | Baselin (mean ± SD) | 12 weeks f-up (mean ± SD) | p value |
|---|---|---|---|
Day-time urinary frequency/day | 10.1 ± 2.2 | 6 ± 1.1 | < 0.0001 |
Night-time urinary frequency/day | 1.6 ± 1.2 | 0.7 ± 0.8 | 0.0001 |
Daily urgency episodes | 5.2 ± 2.3 | 2.3 ± 1.8 | < 0.0001 |
Urge urinary incontinence frequency/day | 2.1 ± 1.3 | 0.7 ± 0.9 | < 0.0001 |
Qmax(ml/sec) | 25.1 ± 8.3 | 25.2 ± 7.9 | 0.83 |
Post-void residual volume(ml) | 5.8 ± 9.5 | 3 ± 5.8 | 0.32 |